A study on the immunohistochemical expression of napsin A in oral squamous cell carcinomas, intraepithelial neoplasia, and normal oral mucosa

References

• Stelow EB, Yaziji H. Immunohistochemistry, carcinomas of unknown primary, and incidence rates. Semin Diagn Pathol. 2018;35(2):143–152.
   PubMed Web of Science ®Google Scholar
• Hirano T, Auer G, Maeda M, et al. Human tissue distribution of TA02, which is homologous with a new type of aspartic proteinase, napsin A. Jpn J Cancer Res. 2000;91(10):1015–1021.
   PubMedGoogle Scholar
• Bishop JA, Sharma R, Illei PB. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma. Hum Pathol. 2010;41(1):20–25.
   PubMed Web of Science ®Google Scholar
• Ueno T, Linder S, Elmberger G. Aspartic proteinase napsin is a useful marker for diagnosis of primary lung adenocarcinoma. Br J Cancer. 2003;88(8):1229–1233.
   PubMed Web of Science ®Google Scholar
• Hirano T, Gong Y, Yoshida K, et al. Usefulness of TA02 (napsin A) to distinguish primary lung adenocarcinoma from metastatic lung adenocarcinoma. Lung Cancer. 2003;41(2):155–162.
   PubMed Web of Science ®Google Scholar
• Inamura K, Satoh Y, Okumura S, et al. Pulmonary adenocarcinomas with enteric differentiation: histologic and immunohistochemical characteristics compared with metastatic colorectal cancers and usual pulmonary adenocarcinomas. Am J Surg Pathol. 2005;29(5):660–665.
   PubMed Web of Science ®Google Scholar
• Suzuki A, Shijubo N, Yamada G, et al. Napsin is useful to distinguish primary lung adenocarcinoma from adenocarcinomas of other organs. Pathol Res Pract. 2005;201(8–9):579–586.
   PubMed Web of Science ®Google Scholar
• Dejmek A, Naucler P, Smedjeback A, et al. Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions. Diagn Cytopathol. 2007;35(8):493–497.
   PubMed Web of Science ®Google Scholar
• Stoll LM, Johnson MW, Gabrielson E, et al. The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas. Cancer Cytopathol. 2010;118(6):441–449.
   PubMed Web of Science ®Google Scholar
• Terry J, Leung S, Laskin J, et al. Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples. Am J Surg Pathol. 2010;34(12):1805–1811.
   PubMed Web of Science ®Google Scholar
• Yang M, Nonaka D. A study of immunohistochemical differential expression in pulmonary and mammary carcinomas. Mod Pathol. 2010;23(5):654–661.
   PubMed Web of Science ®Google Scholar
• Fatima N, Cohen C, Lawson D, et al. TTF-1 and napsin A double stain: a useful marker for diagnosing lung adenocarcinoma on fine needle aspiration cell blocks. Cancer Cytopathol. 2011;119(2):127–133.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay S, Katzenstein AL. Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6. Am J Surg Pathol. 2011;35(1):15–25.
   PubMed Web of Science ®Google Scholar
• Ye J, Findeis-Hosey JJ, Yang Q, et al. Combination of Napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung. Appl Immunohistochem Mol Morphol. 2011;19(4):313–317.
   PubMedGoogle Scholar
• Piljić Burazer M, Mladinov S, Ćapkun V, et al. The utility of thyroid transcription factor 1 (TTF-1), napsin A, Excision Repair Cross-Complementing 1 (ERCC1), Anaplastic Lymphoma Kinase (ALK) and the Epidermal Growth Factor Receptor (EGFR) expression in small biopsy in prognosis of patients with lung adenocarcinoma - a retrograde single-center study from Croatia. Med Sci Monit. 2017;23:489–497.
   PubMed Web of Science ®Google Scholar
• Zhu B, Rohan SM, Lin X. Immunoexpression of napsin A in renal neoplasms. Diagn Pathol. 2015;10:4.
   PubMed Web of Science ®Google Scholar
• Yamashita Y, Nagasaka T, Naiki-Ito A, et al. Napsin A is a specific marker for ovarian clear cell adenocarcinoma. Modern Pathol. 2015;28(1):111–117.
   PubMed Web of Science ®Google Scholar
• Iwamoto M, Nakatani Y, Fugo K, et al. Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium. Hum Pathol. 2015;46(7):957–962.
   PubMed Web of Science ®Google Scholar
• Nocini R, Lippi G, Mattiuzzi C. Biological and epidemiologic updates on lip and oral cavity cancers. Ann Cancer Epidemiol. 2020;4:1–6.
   Google Scholar
• Epstein JB, Kish RV, Hallajian L, et al. Head and neck, oral, and oropharyngeal cancer: a review of medicolegal cases. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119(2):177–186.
   PubMed Web of Science ®Google Scholar
• Kadivar M, Boozari B. Applications and limitations of immunohistochemical expression of Napsin-A” in distinguishing lung adenocarcinoma from adenocarcinomas of other organs. Appl Immunohistochem Mol Morphol. 2013;21(3):191–195.
   PubMedGoogle Scholar
• Wu J, Zhang Y, Ding T, et al. Napsin A expression in subtypes of thyroid tumors: comparison with lung adenocarcinomas. Endocr Pathol. 2020;31(1):39–45.
   PubMed Web of Science ®Google Scholar
• Ju BH, Wang JM, Yang B, et al. Morphologic and Immunohistochemical study of clear cell carcinoma of the uterine endometrium and cervix in comparison to ovarian clear cell carcinoma. Int J Gynecol Pathol. 2018;37(4):388–396.
   PubMed Web of Science ®Google Scholar
• Pereira TC, Share SM, Magalhães AV, et al. Can we tell the site of origin of metastatic squamous cell carcinoma? An immunohistochemical tissue microarray study of 194 cases. AIMM. 2011;19(1):10–14.
   Google Scholar
• Turner BM, Cagle PT, Sainz IM, et al. Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray. Arch Pathol Lab Med. 2012;136(2):163–171.
   PubMed Web of Science ®Google Scholar